SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-454548
Filing Date
2012-11-06
Accepted
2012-11-06 16:20:04
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398766d10q.htm 10-Q 662075
2 EX-10.2 d398766dex102.htm EX-10.2 40944
3 EX-31.1 d398766dex311.htm EX-31.1 6608
4 EX-31.2 d398766dex312.htm EX-31.2 6831
5 EX-32.1 d398766dex321.htm EX-32.1 4761
  Complete submission text file 0001193125-12-454548.txt   4650391

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxa-20120930.xml EX-101.INS 590483
7 XBRL TAXONOMY EXTENSION SCHEMA alxa-20120930.xsd EX-101.SCH 52963
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20120930_cal.xml EX-101.CAL 51134
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20120930_def.xml EX-101.DEF 163295
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20120930_lab.xml EX-101.LAB 389339
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20120930_pre.xml EX-101.PRE 271294
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 121183459
SIC: 2834 Pharmaceutical Preparations